Skip to main content
perspectives
We are passionate about using our voices to advance our mission of developing life-transforming therapies for people living with serious muscle diseases.
We are passionate about using our voices to advance our mission of developing life-transforming therapies for people living with serious muscle diseases.
April 24, 2023
Cultivating A Dynamic Culture Centered Around Purpose-Driven Values
By Kate Mitchell, Vice President, Head of Human Resources
Read more
Sep 15, 2022 |

Lessons Learned on Preparing to Weather the Inevitable Challenges in Biotech

by Joshua Brumm,
President & CEO of Dyne

Read more
Oct 7, 2021 |

From the Trenches: A LifeSci VC blog

by Josh Brumm

Read more
Sep 15, 2021 | Blog

Starting a New Tradition of Support

by Molly White, Dyne’s vice president, global head of patient advocacy and engagement

Read more
Jul 8, 2021 |

Playing To Win: Building A Position Of Strength In Biotech

by Josh Brumm

Read more
April 28, 2021 | BLOG

Toward a brighter future: targeting the genetic basis of rare muscle diseases

By Romesh Subramanian, Ph.D.

Read more
April 8, 2021 | BLOG

Scaling culture with growth: how to maintain your startup’s “special sauce”

By Joshua Brumm

Read more
Jan 8, 2021 | Life Science Leader panel

Preparing to pitch in a virtual world

Featuring Joshua Brumm

Watch
Dec 16, 2020 | BLOG

Beyond the balance sheet: thinking broadly about dilution in building a transformative biotech

By Joshua Brumm

Read more
Dec 14, 2020 | BLOG

Voice of the patient – the biopharma perspective

By Molly White

Read more
Additional content
Stay connected with us on
LinkedIn, X and Facebook.

Hear more from Dyne Therapeutics

Load More

Hear more from our CEO, Joshua Brumm

Our #Dynamos are truly a special group, and I can’t thank this team enough for their commitment and dedication to advance therapeutics that could transform patients’ lives. #EmployeeAppreciationDay